- Home
- MLYS vs PRKS Comparison
MLYS vs PRKS Comparison
Compare MLYS & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- PRKS
- Stock Information
- Founded
- MLYS 2019
- PRKS 1959
- Country
- MLYS United States
- PRKS United States
- Employees
- MLYS N/A
- PRKS N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MLYS Health Care
- PRKS Health Care
- Exchange
- MLYS Nasdaq
- PRKS Nasdaq
- Market Cap
- MLYS 3.1B
- PRKS 2.8B
- IPO Year
- MLYS 2023
- PRKS 2013
- Fundamental
- Price
- MLYS $38.06
- PRKS $55.23
- Analyst Decision
- MLYS Strong Buy
- PRKS Buy
- Analyst Count
- MLYS 6
- PRKS 11
- Target Price
- MLYS $42.60
- PRKS $57.73
- AVG Volume (30 Days)
- MLYS 1.6M
- PRKS 899.7K
- Earning Date
- MLYS 11-10-2025
- PRKS 11-06-2025
- Dividend Yield
- MLYS N/A
- PRKS N/A
- EPS Growth
- MLYS N/A
- PRKS N/A
- EPS
- MLYS N/A
- PRKS 3.77
- Revenue
- MLYS N/A
- PRKS $1,707,446,000.00
- Revenue This Year
- MLYS N/A
- PRKS $0.85
- Revenue Next Year
- MLYS N/A
- PRKS $2.30
- P/E Ratio
- MLYS N/A
- PRKS $14.64
- Revenue Growth
- MLYS N/A
- PRKS N/A
- 52 Week Low
- MLYS $8.24
- PRKS $37.68
- 52 Week High
- MLYS $41.09
- PRKS $60.83
- Technical
- Relative Strength Index (RSI)
- MLYS 62.11
- PRKS 64.15
- Support Level
- MLYS $37.32
- PRKS $51.20
- Resistance Level
- MLYS $40.51
- PRKS $53.08
- Average True Range (ATR)
- MLYS 2.09
- PRKS 1.58
- MACD
- MLYS -0.77
- PRKS 0.35
- Stochastic Oscillator
- MLYS 43.86
- PRKS 91.34
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.